Haemonetics (HAE) Tax Provisions (2009 - 2026)

Haemonetics has reported Tax Provisions for 18 years, with the latest figure at $14.6 million in Q2 2026.

• On a quarterly basis, Tax Provisions rose 31.08% year-over-year to $14.6 million in Q2 2026; TTM through Jun 2026 was $34.2 million, a 27.66% decrease from a year earlier, with the FY2026 full-year figure at $30.7 million, down 30.79% from the prior year.
• Tax Provisions was $14.6 million for Q2 2026 at Haemonetics, up from -$8.3 million in the prior quarter.
• The five-year high for Tax Provisions was $15.2 million in Q4 2025, with the low at -$8.3 million in Q1 2026.
• Average Tax Provisions over 5 years is $8.6 million, with a median of $9.3 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Tax Provisions jumped 324.21% in 2025, then sank 164.89% in 2026.
• Over 5 years, Tax Provisions stood at $9.3 million in 2022, then surged by 37.63% to $12.8 million in 2023, then fell by 2.95% to $12.4 million in 2024, then rose by 22.64% to $15.2 million in 2025, then slipped by 4.17% to $14.6 million in 2026.
• The last three Tax Provisions figures came in at $14.6 million (Q2 2026), -$8.3 million (Q1 2026), and $15.2 million (Q4 2025), per Business Quant data.